Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 76: 893-901, 1994;
8750-7587/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, T.
Right arrow Articles by Robinson, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, T.
Right arrow Articles by Robinson, M. J.

Journal of Applied Physiology, Vol 76, Issue 2 893-901, Copyright © 1994 by American Physiological Society

ARTICLES

Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation?

T. Ahmed, T. Syriste, R. Mendelssohn, D. Sorace, E. Mansour, M. Lansing, W. M. Abraham and M. J. Robinson
Division of Pulmonary Disease, Mount Sinai Medical Center, Miami Beach, Florida 33140.

We hypothesized that heparin, because of its antiallergic and/or anti-inflammatory properties, modifies airway hyperresponsiveness (AHR). We studied the effects of inhaled heparin on AHR induced by specific antigen or by platelet-activating factor (PAF), a proinflammatory mediator. Specific lung resistance (sRL) was measured in 17 allergic sheep before, immediately after, and serially for up to 2 h after airway challenge with either specific antigen or PAF. Airway responsiveness was expressed as the cumulative provocative dose of carbachol that increased sRL to 4 cmH2O/s [PD4, in breath units (BU; 1 BU = 1 breath of 1% carbachol solution)]. PD4 was determined on a baseline day and on various experimental days 2 h after airway challenge with antigen or PAF, without or after pretreatment with inhaled heparin (1,000 U/kg). Pretreatment with inhaled heparin prevented antigen-induced bronchoconstriction and postantigen AHR. PD4 was 26 +/- 2.6 (SE), 12 +/- 1.7, and 22 +/- 2.8 BU on baseline, antigen control, and postheparin days, respectively. Heparin given immediately after the antigen challenge failed to modify the magnitude and/or duration of antigen-induced bronchoconstrictor response or postantigen AHR. Heparin also failed to prevent PAF-induced changes in sRL and AHR. In vitro heparin inhibited anti-immunoglobin E- and 1,4,5-inositol triphosphate-mediated degranulation of rat peritoneal mast cells without attenuating the effects of the Ca2+ ionophore A-23187. These data suggest that in "acute responders" heparin prevents antigen-induced bronchoconstriction and AHR, possibly by inhibiting 1,4,5-inositol triphosphate-dependent mast cell mediator release and not by its anti-inflammatory action.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
W. M. Abraham, A. Ahmed, I. Serebriakov, I. T. Lauredo, J. Bassuk, J. A. Adams, and M. A. Sackner
Whole-Body Periodic Acceleration Modifies Experimental Asthma in Sheep
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 743 - 752.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. S. Niven and G. Argyros
Alternate Treatments in Asthma
Chest, April 1, 2003; 123(4): 1254 - 1265.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. M. ABRAHAM, A. GILL, A. AHMED, M. W. SIELCZAK, I. T. LAUREDO, Y. BOTINNIKOVA, K.-C. LIN, B. PEPINSKY, D. R. LEONE, R. R. LOBB, et al.
A Small-Molecule, Tight-binding Inhibitor of the Integrin alpha 4beta 1 Blocks Antigen-induced Airway Responses and Inflammation in Experimental Asthma in Sheep
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 603 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. SUZUKI and A. N. FREED
Heparin Inhibits Eicosanoid Metabolism and Hyperventilation-induced Bronchoconstriction in Dogs
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1850 - 1854.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
T. Ahmed, J. Ungo, M. Zhou, and C. Campo
Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides
J Appl Physiol, May 1, 2000; 88(5): 1721 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. AHMED, B. J. GONZALEZ, and I. DANTA
Prevention of Exercise-induced Bronchoconstriction by Inhaled Low-molecular-weight Heparin
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 576 - 581.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
C. Campo, J. F. Molinari, J. Ungo, and T. Ahmed
Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses
J Appl Physiol, February 1, 1999; 86(2): 549 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. F. MOLINARI, C. CAMPO, S. SHAKIR, and T. AHMED
Inhibition of Antigen-induced Airway Hyperresponsiveness by Ultralow Molecular-weight Heparin
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Martinez-Salas, R. Mendelssohn, W. M. Abraham, B. Hsiao, and T. Ahmed
Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence
J Appl Physiol, January 1, 1998; 84(1): 222 - 228.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online